Outcome Measures: |
Primary: Assessment of PK (pharmacokinetic) parameter: Cmax, Sotagliflozin: Maximum plasma concentration (Cmax), From 0 to 120 hours after SAR439954 intake|Assessment of PK parameter: AUClast, Sotagliflozin: Area under the concentration-time curve from 0 to last quantifiable concentration (AUClast), From 0 to 120 hours after SAR439954 intake|Assessment of PK parameter: AUC, Sotagliflozin: Area under the concentration-time curve from 0 to infinity, From 0 to 120 hours after SAR439954 intake | Secondary: Assessment of PK parameter: Tmax, Sotagliflozin: Time to reach maximum plasma concentration (Tmax), From 0 to 120 hours after SAR439954 intake|Assessment of PK parameter: t1/2, Sotagliflozin: Terminal elimination half life (T1/2), From 0 to 120 hours after SAR439954 intake|Assessment of PK parameter: Vz/F, Sotagliflozin: Apparent volume of distribution during terminal phase after non-intravenous administration Vz/F, From 0 to 120 hours after SAR439954 intake|Assessment of PK parameter: CL/F, Sotagliflozin: Apparent total body clearance of a drug from the plasma (CL/F), From 0 to 120 hours after SAR439954 intake|Assessment of PK parameter: Cmax, Sotagliflozin 3-O-glucuronide: Maximum plasma concentration (Cmax), From 0 to 120 hours after SAR439954 intake|Assessment of PK parameter: AUC, Sotagliflozin 3-O-glucuronide: Area under the concentration-time curve from 0 to infinity, From 0 to 120 hours after SAR439954 intake|Assessment of PK parameter: AUClast, Sotagliflozin 3-O-glucuronide: Area under the concentration-time curve from 0 to last quantifiable concentration (AUClast), From 0 to 120 hours after SAR439954 intake|Assessment of PK parameter: Tmax, Sotagliflozin 3-O-glucuronide: Time to reach maximum plasma concentration (Cmax), From 0 to 120 hours after SAR439954 intake|Assessment of PK parameter: t1/2, Sotagliflozin 3-O-glucuronide: Terminal elimination half life (T1/2), From 0 to 120 hours after SAR439954 intake|Treatment emergent adverse events (TEAE), Number treatment emergent adverse events, From 0 to 144 hours after SAR439954 intake
|